Can you provide the last earnings date for GENMAB A/S?
GENMAB A/S (GE9.DE) last reported earnings on 2/18/2026.
FRA:GE9 • DK0010272202
Past quarterly earnings results for GENMAB A/S (GE9.DE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 2.13 | 3.50 | -39.11% | -75.02% | 1.058B | 1.056B | 0.19% | 14.91% |
| Q3 2025 | 6.46 | 4.74 | 36.36% | 121.44% | 1.022B | 1.011B | 1.09% | 25.21% |
| Q2 2025 | 5.42 | 4.33 | 25.14% | 73.04% | 925M | 938.97M | -1.49% | 18.66% |
| Q1 2025 | 3.05 | 2.04 | 49.64% | 3.77% | 715M | 774.29M | -7.66% | 18.57% |
| Q4 2024 | 8.53 | 3.63 | 134.67% | 511.09% | 920.715M | 904.1M | 1.84% | 36.36% |
| Q3 2024 | 2.92 | 3.27 | -10.91% | -38.15% | 816.23M | 840.67M | -2.91% | 17.87% |
| Q2 2024 | 3.13 | 3.06 | 2.30% | 3.98% | 779.546M | 755.36M | 3.20% | 27.96% |
| Q1 2024 | 2.94 | 1.73 | 69.78% | 494.29% | 603M | 560.12M | 7.66% | 47.62% |
| Q4 2023 | 1.40 | 3.41 | -59.06% | 15.92% | 675.218M | 675.52M | -0.04% | -4.20% |
| Q3 2023 | 4.72 | 2.97 | 58.98% | -11.00% | 692.501M | 650.76M | 6.41% | 25.12% |
| Q2 2023 | 3.01 | 2.96 | 1.92% | -26.58% | 609.22M | 616.41M | -1.17% | 34.53% |
| Q1 2023 | 0.49 | 0.80 | -38.26% | -53.45% | 408.484M | 409.55M | -0.26% | 27.87% |
| Q4 2022 | 1.20 | 3.86 | -68.82% | -27.62% | 704.807M | 696.28M | 1.22% | 79.48% |
| Q3 2022 | 5.30 | 2.52 | 110.03% | 148.25% | 553.49M | 483.66M | 14.44% | 51.13% |
| Q2 2022 | 4.10 | 1.97 | 108.67% | 445.88% | 452.865M | 419.69M | 7.90% | 41.79% |
| Q1 2022 | 1.06 | 0.79 | 33.66% | -60.52% | 319.465M | 298.02M | 7.20% | 24.69% |
| Q4 2021 | 1.66 | 1.29 | 29.34% | 18.61% | 392.698M | 392.42M | 0.07% | 19.91% |
| Q3 2021 | 2.13 | 1.31 | 62.88% | 69.13% | 366.23M | 346.19M | 5.79% | 35.32% |
| Q2 2021 | 0.75 | 0.75 | -0.39% | -90.09% | 319.399M | 271.16M | 17.79% | -60.30% |
| Q1 2021 | 2.69 | 0.67 | 301.09% | 345.81% | 256.206M | 229.36M | 11.70% | 94.60% |
| Q4 2020 | 1.40 | 1.23 | 13.91% | - | 327.506M | 299.13M | 9.49% | - |
| Q3 2020 | 1.26 | 0.98 | 28.91% | - | 270.63M | 238.59M | 13.43% | - |
| Q2 2020 | 7.58 | 8.57 | -11.58% | - | 804.589M | 853.76M | -5.76% | - |
| Q1 2020 | 0.60 | 0.20 | 199.67% | - | 131.659M | 133.72M | -1.54% | - |
Notes
GENMAB A/S (GE9.DE) last reported earnings on 2/18/2026.
GENMAB A/S (GE9.DE) missed EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, GENMAB A/S (GE9.DE) has beaten EPS estimates in 3 out of 4 releases.